PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Multiple Sclerosis Center and Center for Translational & Computational Neuroimmunology, Department of Neurology and Taub Institute for Research on Alzheimer\'s Disease and the Aging Brain, Columbia University Irving Medical Center, New York, New York, USA.\', \'New York Presbyterian Hospital, New York, New York, USA.\', \'Program in Translational Neuroimmunology, Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.\', \'Department of Neurology, Children\'s Hospital of Pennsylvania, Philadelphia, Pennsylvania, USA.\', \'Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.\', \'Department of Neurology, University of Rochester Medical Center, School of Medicine and Dentistry, Rochester, New York, USA.\', \'Department of Neurology, Yale University, New Haven, Connecticut, USA.\', \'Division of Neurology, Department of Medicine, St Michael\'s Hospital, University of Toronto, Toronto, Ontario, Canada.\', \'Department of Neurology, Jacobs Multiple Sclerosis Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA.\', \'The Multiple Sclerosis Center of Northeastern New York, Latham, New York, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/acn3.51314
?:doi
?:hasPublicationType
?:journal
  • Annals of clinical and translational neurology
is ?:pmid of
?:pmid
?:pmid
  • 33616290
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.284
?:rankingScore_hIndex
  • 22
?:title
  • Manifestations and impact of the COVID-19 pandemic in neuroinflammatory diseases.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all